SSTR3 and neuroendocrine neoplasm: SSTR3 expression has been reported by Lupp et al. in 84% and by Mizutani et al. in 52–55% of the neuroendocrine tumors of the intestine [26, 31], Other studies report incidences of about 26–71% [27, 30].